Drug Development

Articles

The Pharmacopoeial Discussion Group approved monographs and plans to harmonize several others.

Pharmacopeias Continue Harmonization Program

Hovione expands drug substance and HPAPI capacity in East Windsor, New Jersey.

Hovione Breaks Ground on API Facility in New Jersey

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Effective harvesting and purification processes play an essential role in ensuring that biopharmaceutical manufacturing processes provide biologic drug substances with uniform and consistent properties.

Ensuring Biologic API Uniformity

The collaboration will provide GMP manufacturing ahead of future clinical studies.

CMC Biologics Will Manufacture F-star mAb² Bispecific Antibodies

A new 20,000-L microbial biologics facility in Ireland will be operational by 2018 for Fujifilm Diosynth's contract development and manufacturing customers.

Fujifilm Diosynth Announces Collaboration With MSD on Large-Scale Biologics Facility

Process analytical technology paved the way for continuous manufacturing.

PAT: “Gateway Drug” to the 21st Century for the Pharma Industry

Application of flow chemistry for small-molecule API synthesis continues to expand thanks to research efforts.

Steps Closer to the Adoption of Continuous Processing

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

As the battle for ownership over the use of CRISPR to edit DNA heats up, some of the CRISPR pioneers refocus their efforts to demonstrate the technology’s applications for editing RNA.

Using a New CRISPR Effector to Edit RNA

Xellia, a generic anti-infective drug manufacturing company, is constructing a laboratory services building at its manufacturing site in Budapest, Hungary.

Xellia Builds Testing Services Lab at Budapest Manufacturing Site

W.R. Grace & Co. will sell its chromatography product lines, which includes chromatography instruments, columns, and other related products.

APIs and Excipients